ArticleJournal of Korean medical science2013
Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
Article in Journal of Korean medical science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global prevalence and antibiotic resistance in clinical isolates ofFrontiers in medicine · 2023Pooled it
- Article
- Evaluation of the In Vitro Synergistic Activity of Ceftazidime/Avibactam AgainstPharmaceuticals (Basel, Switzerland) · 2025Article
- Investigation and Management of a Small Outbreak of Septic Knee Arthritis Following Knee Arthroscopy byJournal of medical cases · 2025Article
- Osteomyelitis due to Stenotrophomonas maltophilia treated with trimethoprim-sulfamethoxazole monotherapy.IDCases · 2023Article
- Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Patients withJournal of clinical medicine · 2022Article
- Risk Factors for Mortality in Hospitalized Patients withInfection and drug resistance · 2022Article
- Article
- A prospective study of microbiological characterization and clinical facets ofIranian journal of microbiology · 2020Article
- Characterization of Novel Broad-Host-Range Bacteriophage DLP3 Specific toFrontiers in microbiology · 2020Article
- Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.BMC infectious diseases · 2019Article
- In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolatesTurkish journal of medical sciences · 2019Article
- Antimicrobial Susceptibility ofOpen forum infectious diseases · 2019Article
- Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due toBioMed research international · 2019Article
- Article
- A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity againstThe Malaysian journal of medical sciences : MJMS · 2017Article
- Evolution ofFrontiers in microbiology · 2017Article
- Review
- Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.Internal medicine (Tokyo, Japan) · 2017Observational
- Surveillance of Dihydropteroate Synthase Genes inFrontiers in microbiology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to determine antimicrobial susceptibility of recent clinical Stenotrophomonas maltophilia isolates from Korea, and to compare the activity levels of several combinations of antimicrobials. A total of 206 non-duplicate clinical isolates of S. maltophilia was collected in 2010 from 11 university hospitals. Antimicrobial susceptibility testing was performed using the Clinical Laboratory Standards Institute agar dilution method. In vitro activity of antimicrobial combinations was tested using the checkerboard method. The susceptibility rates to trimethoprim-sulfamethoxazole and minocycline were 96% and 99%, respectively. The susceptibility rate to levofloxacin was 64%. All of four antimicrobial combinations showed synergy against many S. maltophilia isolates. A combination of trimethoprim-sulfamethoxazole plus ticarcillin-clavulanate was most synergistic among the combinations. None of the combinations showed antagonistic activity. Therefore, some of the combinations may be more useful than individual drugs in the treatment of S. maltophilia infection. Further clinical studies are warranted to validate our in vitro test results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.